HPV Vaccination: Prevention of Cervical Cancer in Serbia and in Europe
The identification of the high-risk human papilloma viruses (HPVs) as a cause of cervical cancer offered the possibility for the development of a HPV vaccine. Twenty years after this identification of the HPV types, the first HPV vaccine came to the market. There are three HPV vaccines today on the market, all containing the virus-like particles (V...
By HOLGER STARK, ALEKSANDRA ŽIVKOVIĆ